# Down's syndrome cells 'fixed' in first step towards chromosome therapy

Researchers shut down the extra chromosome responsible for Down's syndrome, paving the way for future treatments

- Share
- Tweet this
- Email

- Ian Sample, science correspondent
- The Guardian, Wednesday 17 July 2013 18.00 BST
- Jump to comments (…)

People with Down's syndrome are at greater risk of heart defects, leukaemia and early-onset dementia. Photograph: Getty Images

Scientists have corrected the genetic fault that causes Down's syndrome – albeit in isolated cells – raising the prospect of a radical therapy for the disorder.

In an elegant series of experiments, US researchers took cells from people with DS and silenced the extra chromosome that causes the condition. A treatment based on the work remains a distant hope, but scientists in the field said the feat was the first major step towards a "chromosome therapy" for Down's syndrome.

"This is a real technical breakthrough. It opens up whole new avenues of research," said Elizabeth Fisher, professor of neurogenetics at UCL, who was not involved in the study. "This is really the first sniff we've had of anything to do with gene therapy for Down's syndrome."

Around 750 babies are born with DS in Britain each year while globally between one in a 1000 and one in 1100 births are DS babies. Most experience learning difficulties.

Despite advances in medical care that allow most to live well into middle age, those who have the disorder are at risk of heart defects, bowel and blood disorders, and thyroid problems.

Though a full treatment is still many years off, the work will drive the search for therapies that improve common symptoms of DS, from immune and gastrointestinal problems, to childhood leukaemia and early-onset dementia.

"This will accelerate our understanding of the cellular defects in Down's syndrome and whether they can be treated with certain drugs," said Jeanne Lawrence, who led the team at the University of Massachusetts.

"The long-range possibility – and it's an uncertain possibility – is a chromosome therapy for Down's syndrome. But that is 10 years or more away. I don't want to get people's hopes up."

In a healthy person, almost every cell in the body carries 23 pairs of chromosomes, which hold nearly all of the genes needed for human life. But glitches in the early embryo can sometimes leave babies with too many chromosomes. Down's syndrome arises when cells have an extra copy of chromosome 21.

Lawrence's team used "genome editing", a procedure that allows DNA to be cut and pasted, to drop a gene called XIST into the extra chromosome in cells taken from people with Down's syndrome.

Once in place, the gene caused a buildup of a version of a molecule called RNA, which coated the extra chromosome and ultimately shut it down.

Previous studies found that the XIST gene is crucial for normal human development. Sex is determined by the combination of X and Y chromosomes a person inherits: men are XY, and women are XX. The XIST gene sits on the X chromosome, but is only active in women. When it switches on, it silences the second X chromosome.

Lawrence's work shows that the gene can shut down other chromosomes too, a finding that paves the way for treating a range of other "trisomy" disorders, such as Edward syndrome and Patau syndrome, caused by extra copies of chromosomes 18 and 13 respectively.

Writing in the journal Nature, the team describes how cells corrected for an extra chromosome 21 grew better, and developed more swiftly into early-stage brain cells. The work, the researchers write, "surmounts the major first step towards potential development of chromosome therapy".

The work is already helping scientists to tease apart how an extra chromosome 21 causes a raft of problems that strike people with Down's syndrome at various ages. "By the time people with Down's syndrome are in their 60s, about 60% will succumb to dementia. One question is, if we could turn off the extra chromosome in adults, would that stop or ameliorate their dementia?" said Fisher. Another approach would cut the risk of leukaemia by silencing the extra chromosome in bone marrow cells.

The US team has already begun work that aims to prevent Down's syndrome in mice, by silencing the extra chromosome 21 in early-stage embryos. "That would correct the whole mouse, but it's not really practical in humans," said Lawrence.

A chromosome therapy for humans would be fraught with practical and ethical difficulties. To prevent Down's syndrome, the genome editing would have to be performed on an embryo or foetus in the womb, and correct most, if not all, of the future child's cells. That is far beyond what is possible, or allowed, today.

- Print this
- Share
- Contact us

### Send to a friend

Sender's name
Recipient's email address

Your IP address will be logged

### Share

Short link for this page: http://gu.com/p/3hcjn

- StumbleUpon
- reddit
- Tumblr
- Digg
- LinkedIn
- Google Bookmarks
- del.icio.us
- livejournal
- Facebook
- Twitter

### Contact us

- Contact the Science editor
  science@guardian.co.uk
- Report errors or inaccuracies: reader@guardian.co.uk
- Letters for publication should be sent to: letters@guardian.co.uk

- If you need help using the site: userhelp@guardian.co.uk
- Call the main Guardian and Observer switchboard:
  +44 (0)20 3353 2000
- - Advertising guide
  - License/buy our content

Article history

### About this article

Down's syndrome cells 'fixed' in first step towards chromosome therapy

This article was published on guardian.co.uk at 18.00 BST on Wednesday 17 July 2013. A version appeared on p9 of the Main section section of the Guardian on Thursday 18 July 2013. It was last modified at 12.44 BST on Thursday 18 July 2013.

#### Science

- Genetics ·
- Human biology ·
- Biology ·
- Medical research

#### Society

- Down's syndrome ·
- Health

#### UK news

#### World news

More news

- ### More medical research

- Intelligent knife tested on cancer patients in London hospitals

  Hi-tech form of electric scalpel can identify malignant tissue in cancer patients having operations with 100% accuracy

- The amazing story of IVF: 35 years and five million babies later

- Australia's chief scientist sounds antibiotic resistance warning

- Air pollution linked to higher risk of lung cancer and heart failure

- 'Designer babies': the ultimate privileged elite?

- IVF baby born using revolutionary genetic-screening process

- Share
- Tweet this
- Email

### Today's best video

- #### Tour de France 2013 highlights: Chris Froome wins stage 17

  Chris Froome extends his lead over Alberto Contador by nine seconds during a hilly and wet Chorges time trial of stage 17

- #### How to dress: cool summer pastels

  Jess Cartner-Morley shows you how to retain a summery look even after the heatwave

- #### Streaker at Australian rugby match

  A streaker caused a try to be disallowed at the State of Origin III game

- #### 'Invisibility suit' promises to protect surfers from sharks

  Promotional video for 'shark-proof' wetsuit

### GuardianWitness

- Olympic friendships

  Did you make new friends through the London Olympics? Tell us what you're up to now

- Recipe swap: burgers

  Perfected your homemade burger recipe? Show us how to make it!

- Bruce Springsteen competition

  Win tickets to a screening of the new Springsteen documentary. Video yourself telling us what's so great about The Boss.

- Send us your assignment ideas

  Do you have an idea for an assignment you think should run on GuardianWitness? Let us know.

### Guardian Audio Edition

- Open season on black boys after Trayvon Martin killing

  In this week's edition: calls for calm after George Zimmerman was acquitted of murdering Trayvon Martin are empty words for black families. Listen now

- Healthcare Professionals Network

  ## Today in healthcare: Thursday 18 July

  News, comment, blogposts and tweets across the sector

- Healthcare Professionals Network

  ## How the NHS can build partnerships with other organisations

  Successful partnerships can offer benefits to both the public and private sectors, explains Matthew Harker

- ## More from our Healthcare Network

### On Science

- Most viewed
- Latest

Last 24 hours

1. 1. Sabre rocket engine could open up access to space as never before
2. 2. Down's syndrome cells 'fixed' in first step towards chromosome therapy
3. 3. How astronauts wash their hair in space - video
4. 4. Cosmic gas cloud fights supermassive black hole
5. 5. Cannabis psychosis admissions rose after drug reclassified to Class B
6. More most viewed

Last 24 hours

1. 1. Curiosity rover finds evidence Mars lost its atmosphere 4bn years ago
2. 2. Cosmic gas cloud fights supermassive black hole
3. 3. Cannabis psychosis admissions rose after drug reclassified to Class B
4. 4. A month in space: cosmic clouds and a rocket launch – in pictures
5. 5. How astronauts wash their hair in space - video
6. All today's stories

###

#### This week's bestsellers

1. 1. Ten Billion

   by Stephen Emmott £5.59

2. 2. Norm Chronicles

   by Michael Blastland £9.99

3. 3. Signal and the Noise

   by Nate Silver £6.99

4. 4. Stuff Matters

   by Mark Miodownik £12.99

5. 5. Selfish Gene

   by Richard Dawkins £7.19

Search the Guardian bookshop

### Subscribe to the paper and get digital access

- Choose from one of our four subscription packages and save up to 32%. From just £4.99 a week, you'll receive your papers plus iPhone and iPad access. Learn more

### Sponsored feature

### Top stories in this section

### Top videos

### Most popular

### Today in pictures

- #### BBC Sports Personality of the Year – in pictures

  Bradley Wiggins capped his remarkable sporting year by taking home the big prize at the ceremony in London

- #### Dinner, dusk and dancing Russians: my best winter shot

  A glass of wine with a rough sleeper, Santa in trunks, a thousand partying Muscovites … in a My Best Shot special, top photographers pick the image that sums up winter for them

- #### Monkey adopts kitten – in pictures

  Kimon, an eight-year-old pet female long-tailed monkey, treats a kitten as her baby in Bintan Island, Indonesia

Close
notifications (beta)

- Share
- Tweet this